CSI Market
Sign In | Register

Supernus Pharmaceuticals inc (SUPN) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access SUPN Annual Balance Sheets →
The table below presents a historical view of Supernus Pharmaceuticals inc's balance sheet, supporting analysis of financial position trends.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent175.88
Marketable Securities, Current SH0.29
Cash & Short-term Investments175.00
Accounts receivable214.71
Interest Receivable, Current29.60
Inventories113.24
Other Current Assets127.56
Prepaid Expense And Other Assets Current49.93
Total Current Assets711.22
Equipment/Property/Plant Net29.59
Goodwill net119.43
Intangible Assets446.24
Deferred Costs, Noncurrent AS0.77
Other Assets, Noncurrent90.45
Debt Securities Available For Sale Excluding Accrued Interest Current199.37
Deferred Income Tax Assets Net30.82
Total Assets1,397.69
Liabilities
Accounts Payable and Accrued Liabilities, Current LI109.14
Other Accounts Payable AndAccrued Liabilities109.14
Other Liabilities, Current67.13
Business Combination, Contingent Consideration, Liability, Current BU0.00
Total Current Liabilities285.40
Total Long-term Debt0.00
Other liabilities, Noncurrent49.82
Accrued Product Returns And Rebates189.72
Operating Lease Liability Noncurrent30.27
Deferred Income Tax Liabilities Net-
Total Liabilities335.21
Stockholders' Equity
Common Stock Value0.06
Additional Paid In Capital Common Stock584.58
Retained Earnings / Accumulated Deficit478.13
Accumulated Other Comprehensive Income-0.28
Other Equity-0.28
Common Stockholder's Equity1,062.48
Total Stockholder's Equity1,062.48
Liabilities & Stockholder's Equity1,397.69
4 historic quarters locked

Sign in to unlock the full Supernus Pharmaceuticals inc balance sheet history.

Sign In Create Free Account

About Supernus Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001356576-26-000051

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI